Thomas Diot

Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers

E. Pasquier, Clara Savary, Laura Broutier, 2023, Cell reports. Medicine.

Fusion-negative Rhabdomyosarcoma 3D-organoids as an innovative model to predict resistance to cell death inducers

J. Blay, D. Maucort-Boulch, E. Pasquier, 2022, bioRxiv.